REVIEW ARTICLE
Year : 2012  |  Volume : 3  |  Issue : 2  |  Page : 111-120

Important advances in malaria vaccine research


1 Department of Infectious Diseases, Maharashtra University of Health Sciences, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai, India
2 Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA 32610

Correspondence Address:
Priyanka Jadhav
2811 SW Archer Road, F-47, Brandywine Apts, Gainesville, Florida 32608, USA

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2229-5186.98676

Rights and Permissions

Malaria is one of the most widespread parasitic infection in Asian countries affecting the poor of the poor. In an effort to develop an effective vaccine for the treatment of malaria, various attempts are being made worldwide. If successful, such a vaccine can be effective for treatment of both Plasmodium vivax and Plasmodium falciparum. This would also be able to avoid complications such as drug resistance, resistance to insecticides, nonadherence to the treatment schedule, and eventually high cost of treatment in the resource-limited settings. In the current compilation, the details from the literature were collected by using PubMed and Medline as search engines and searched for terms such as malaria, vaccine, and malaria treatment. This review collates and provides glimpses of the information on the recent malaria vaccine development. The reader will be taken through the historical perspective followed by the approaches to the malaria vaccine development from pre-erythrocytic stage vaccines, asexual stage vaccines, transmission blocking vaccines, etc. Looking at the current scenario of the malaria and treatment strategies, it is an absolute need of an hour that an effective malaria vaccine should be developed. This would bring a revolutionary breakthrough in the treatment modalities especially when there is increasing emergence of resistance to existing drug therapy. It would be of great purpose to serve those living in malaria endemic region and also for travelers which are nonimmune and coming to malaria endemic region. As infection by P. vivax is more prevalent in India and other Asian subcontinent and is often prominent in areas where elimination is being attempted, special consideration is required of the role of vaccines in blocking transmission, regardless of the stages being targeted. Development of vaccines is feasible but with the support of private sector and government organization in terms of regulatory and most importantly financially, being an expensive venture.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4498    
    Printed157    
    Emailed2    
    PDF Downloaded661    
    Comments [Add]    

Recommend this journal